Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

NCT03209401 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT03209401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies
Lead sponsor
Georgetown University
Phase
Phase 1
Overall status
Terminated
Start date
October 13, 2017
Completion date
October 16, 2023
Enrollment
23 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

homologous recombination deficiency, solid tumor, adult